iyuzeh Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Iyuzeh, and when can generic versions of Iyuzeh launch?

Iyuzeh is a drug marketed by Thea Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-seven countries.

The generic ingredient in IYUZEH is latanoprost. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Iyuzeh

A generic version of iyuzeh was approved as latanoprost by AMRING PHARMS on March 22^nd, 2011.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for iyuzeh?
What are the global sales for iyuzeh?
What is Average Wholesale Price for iyuzeh?

Summary for iyuzeh

International Patents:	34
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	79
Patent Applications:	6,239
Drug Prices:	Drug price information for iyuzeh
What excipients (inactive ingredients) are in iyuzeh?	iyuzeh excipients list
DailyMed Link:	iyuzeh at DailyMed

Drug patent expirations by year for iyuzeh

US Patents and Regulatory Information for iyuzeh

iyuzeh is protected by one US patents.

Patents protecting iyuzeh

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Thea Pharma	IYUZEH	latanoprost	SOLUTION/DROPS;OPHTHALMIC	216472-001	Dec 13, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for iyuzeh

See the table below for patents covering iyuzeh around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	2588078	SYSTEME DE DELIVRANCE POLYMERIQUE D'UNE SOLUTION NON VISQUEUSE A BASE DE PROSTAGLANDINE SANS CONSERVATEUR (POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION)	⤷ Sign Up
Japan	2015038099	防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム (POLYMER DELIVERY SYSTEM FOR NON-VISCOUS PROSTAGLANDIN-BASED OPHTHALMIC SOLUTION CONTAINING NO ANTISEPTIC)	⤷ Sign Up
Croatia	P20140631		⤷ Sign Up
Eurasian Patent Organization	201291307	СИСТЕМА ПОДАЧИ НЕВЯЗКОГО ПОЛИМЕРНОГО РАСТВОРА НА ОСНОВЕ ПРОСТАГЛАНДИНА, НЕ СОДЕРЖАЩЕГО КОНСЕРВАНТ	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for iyuzeh

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0364417	61/1997	Austria	⤷ Sign Up	PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718
0364417	97C0128	France	⤷ Sign Up	PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
0364417	9690031-1	Sweden	⤷ Sign Up	PRODUCT NAME: LATANOPROST
3461484	122021000036	Germany	⤷ Sign Up	PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for iyuzeh

Patents protecting iyuzeh

Make Better Decisions: Try a trial or see plans & pricing